ALBLU Bluelinea Société Anonyme

EPA · FR · Healthcare · Medical Devices · bluelinea.com

0.1700EUR0.00%Mkt Cap: 4.02M $P/E: —Today

Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also prov…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap4.02M USD

Enterprise Value6.14M USD

Revenue (TTM)12.09M USD

Gross Profit6.88M USD

Net Income (TTM)-1.64M USD

Revenue/Share0.60 EUR

Last Price0.1700 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees89

CountryFR

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA15.12

EV/Revenue0.51

P/S0.33

P/B1.10

EPS (TTM)-0.07

EPS (Forward)—

52W Range

0.12508% of range0.6900

52W High0.6900 EUR

52W Low0.1250 EUR

Profitability

Gross Margin59.03%

Oper. Margin-11.79%

EBITDA Margin3.36%

Profit Margin-14.05%

ROE-52.77%

ROA-16.31%

Growth

Revenue Growth-8.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-824.68K USD

CapEx (TTM)1.07M USD

FCF Margin-6.83%

FCF Yield-20.53%

Net Debt2.73M USD

Net Debt/EBITDA6.73

Balance Sheet

Debt/Equity1.16

Current Ratio0.75

Quick Ratio0.60

Book Value/Sh0.15 EUR

Cash/Share0.04 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.21.77M

Float—

Insiders0.00%

Institutions65.08%

Technical

SMA 500.1748 (-2.8%)

SMA 2000.3752 (-54.7%)

Beta0.22

S&P 52W Chg14.58%

Avg Vol (30d)4.57K

Avg Vol (10d)3.47K

Technical Indicators

RSI (14)52.4

MACD-0.0093

MACD Signal-0.0142

MACD Hist.+0.0048

BB Upper0.1810 EUR

BB Middle0.1536 EUR

BB Lower0.1262 EUR

BB Width35.73%

ATR (14)0.0110 EUR

Vol Ratio (20d)0.18x